arrow
R

Rodrigo Martino

hospital santa creu i sant pau
H指数:72
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Post-transplant cyclophosphamide and single-agent tacrolimus as GvHD prophylaxis for allogeneic peripheral blood stem cell transplantation. Comparison between haploidentical and HLA matched/single-allele mismatched donors and impact of lower doses of PTCy

移植后环磷酰胺和单药他克莫司作为allo-PBSCT GVHD预防措施。比较单倍体相合与HLA相合/单等位基因不合供者以及PTCy低剂量影响

2026-11-080
PRE
Correction: Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

更正:费城染色体阳性急性淋巴细胞白血病合并附加细胞遗传学异常的移植结局:欧洲血液与骨髓移植学会急性白血病工作组的研究

2026-08-310
OAAI
Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities

携带附加细胞遗传学异常的费城染色体阳性急性淋巴细胞白血病的移植结果

2026-07-130
OAAI
Central nervous system disorders following haematopoietic stem cell transplantation: a prospective case–control observational study from the Infectious Diseases Working Party and the Transplant Complications Working Party of EBMT

造血干细胞移植后中枢神经系统障碍:一项来自EBMT传染病工作组与移植并发症工作组的病例对照观察性研究

2026-02-260
OAAI
Haploidentical Donor vs. Mismatched Unrelated Donor in Reduced-Intensity Conditioning Stem Cell Transplant, a GETH-TC Study

单倍型相合供者与错配无关供者在减低强度预处理干细胞移植中的比较,一项GETH-TC研究

2026-01-120
PRE
Complications of Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide—A Prospective Study on Behalf of the EBMT Transplant Complications Working Party

haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide的并发症——EBMT移植并发症工作组发起的一项前瞻性研究

2025-12-180
OAAI
Outcomes of primary graft failure in acute myeloid leukemia patients following unrelated transplantation with post-transplant cyclophosphamide: a study from the ALWP/EBMT

异基因移植后应用环磷酰胺的急性髓系白血病患者原发移植物衰竭的结局:一项来自ALWP/EBMT的研究

2025-10-180
OA
Corrigendum to: “Combining three different pre-transplant scores improves predictive value in patients after haploidentical stem cell transplantation with TBF conditioning and PTCy” Journal: Transplant Cell Ther. 2021 Jul;27(7):614.e1-614.e8 doi: 10.1016/j.jtct.2021.03.021

勘误: “Combining three different pre-transplant scores improves predictive value in patients after haploidentical stem cell transplantation with TBF conditioning and PTCy” 期刊:Transplant Cell Ther. 2021年7月;27(7):614.e1-614.e8 doi: 10.1016/j.jtct.2021.03.021

2025-08-080
PRE
Cytomegalovirus DNA Doubling Time for Early Identification of Clinically Significant Infection Episodes in Allogeneic Hematopoietic Stem Cell Transplant Recipients Undergoing Primary Letermovir Prophylaxis: A Multicenter Study

巨细胞病毒DNA倍增时间在原发莱特莫韦预防的异基因造血干细胞移植受者中早期识别临床显著感染事件的应用:一项多中心研究

2025-07-170
OA
Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A study of Infectious Disease Working Party of EBMT

同种异基因造血细胞移植后HHV-6脑炎的临床特征与结局:EBMT感染性疾病工作组的研究

2025-06-030
PRE
Corrigendum to: “Comparison of three strategies of GvHD prophylaxis after T-cell replete haploidentical hematopoietic transplantation: Tacrolimus vs calcineurin inhibitors-MMF vs sirolimus-MMF” Journal: Transplant Cell Ther. 2024 Oct;30(10):1025.e1-1025.e14. doi: 10.1016/j.jtct.2024.07.027

勘误:Comparison of three strategies of GvHD prophylaxis after T-cell replete haploidentical hematopoietic transplantation: Tacrolimus vs calcineurin inhibitors-MMF vs sirolimus-MMF 期刊:Transplant Cell Ther. 2024 Oct;30(10):1025.e1-1025.e14. doi: 10.1016/j.jtct.2024.07.027

2025-06-010
PRE
HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+lymphoma

HSP-CAR30含有高比例的未分化T细胞,可促进难治性CD30+淋巴瘤的持久应答。

BLOOD
IF23.1
2025-01-221
PRE
Comparison of Three Graft-versus-Host Disease Prophylaxis Strategies after T Cell-Replete Haploidentical Hematopoietic Transplantation: Tacrolimus versus Calcineurin Inhibitors plus Mycophenolate Mofetil versus Sirolimus plus Mycophenolate Mofetil
2024-10-010
PRE
Contribution of copy number to improve risk stratification of adult T-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials
2024-08-080
OAAI
PTCy vs CNI-based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT
2024-07-260
OAAI
Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy
2024-06-191
OAAI
Optimization of a home hospitalization program for hematopoietic stem cell transplantation with ehealth integration and clinical pharmacist involvement

ehealth整合和临床药师参与的造血干细胞移植家庭住院计划的优化

2024-06-110
OAAI
Guidelines for the management of Toxoplasma gondii infection and disease in patients with haematological malignancies and after haematopoietic stem-cell transplantation: guidelines from the 9th European Conference on Infections in Leukaemia, 2022
2024-05-012
OAAI
Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
2024-01-110
OAAI
Influence of invasive aspergillosis during acute leukaemia treatment on survival after allogeneic stem cell transplantation: a prospective study of the EBMT Infectious Diseases Working Party
2024-01-013
OAAI